3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Ovarian Neoplasms
44
Lung Neoplasms
29
Neuroblastoma
24
Small Cell Lung Carcinoma
21
Carcinoma, Ovarian Epithelial
19
Fallopian Tube Neoplasms
17
Neoplasms
14
Brain Neoplasms
14
Uterine Cervical Neoplasms
11
Leukemia, Myeloid, Acute
11
Leukemia
11
Retinoblastoma
10
Glioma
9
Recurrence
8
Sarcoma
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Lymphoma
7
Central Nervous System Neoplasms
7
Sarcoma, Ewing
6
Neoplasm Metastasis
6
Lymphoma, Follicular
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Osteosarcoma
5
Gliosarcoma
5
Glioblastoma
5
Endometrial Neoplasms
5
Burkitt Lymphoma
5
Blast Crisis
5
Astrocytoma
5
Wilms Tumor
4
Interventions
Etoposide
10
Cisplatin
9
Cyclophosphamide
7
etoposide phosphate
5
Paclitaxel
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
Carboplatin
5
fludarabine
4
Sirolimus
4
Gemcitabine
4
pembrolizumab
3
fludarabine phosphate
3
Sunitinib
3
Mesna
3
Melphalan
3
Filgrastim
3
Drug Therapy
3
Brentuximab Vedotin
3
Bleomycin
3
Bevacizumab
3
Automobiles
3
tremelimumab
2
sodium thiosulfate
2
pegfilgrastim
2
lutetium Lu 177 dotatate
2
durvalumab
2
Vorinostat
2
Stem Cell Transplantation
2
Oxaliplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neoplasms, Germ Cell and Embryonal
×
Topotecan
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled